Trilogy Capital Inc. Merck & Co., Inc. Transaction History
Trilogy Capital Inc.
- $1.92 Billion
- Q3 2024
A detailed history of Trilogy Capital Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Trilogy Capital Inc. holds 12,037 shares of MRK stock, worth $1.19 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,037
Previous 12,262
1.83%
Holding current value
$1.19 Million
Previous $1.52 Million
10.01%
% of portfolio
0.07%
Previous 0.08%
Shares
16 transactions
Others Institutions Holding MRK
# of Institutions
3,803Shares Held
1.9BCall Options Held
13.5MPut Options Held
11.1M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.14 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.83 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $250B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...